nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—HTR1B—trigeminal nerve—pharynx cancer	0.093	0.181	CbGeAlD
Almotriptan—HTR1D—trigeminal nerve—pharynx cancer	0.09	0.175	CbGeAlD
Almotriptan—HTR1B—cranial nerve—pharynx cancer	0.0663	0.129	CbGeAlD
Almotriptan—HTR1D—cranial nerve—pharynx cancer	0.0641	0.125	CbGeAlD
Almotriptan—CYP2E1—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.031	0.0639	CbGpPWpGaD
Almotriptan—FMO3—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0298	0.0614	CbGpPWpGaD
Almotriptan—CYP2E1—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0272	0.056	CbGpPWpGaD
Almotriptan—FMO3—parotid gland—pharynx cancer	0.0265	0.0515	CbGeAlD
Almotriptan—FMO3—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0261	0.0538	CbGpPWpGaD
Almotriptan—CYP2D6—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.022	0.0453	CbGpPWpGaD
Almotriptan—CYP2D6—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0193	0.0398	CbGpPWpGaD
Almotriptan—CYP1A2—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0187	0.0384	CbGpPWpGaD
Almotriptan—FMO3—Biological oxidations—CNDP2—pharynx cancer	0.0175	0.036	CbGpPWpGaD
Almotriptan—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0164	0.0337	CbGpPWpGaD
Almotriptan—FMO3—Biological oxidations—ADH7—pharynx cancer	0.0158	0.0326	CbGpPWpGaD
Almotriptan—HTR1B—brainstem—pharynx cancer	0.0146	0.0283	CbGeAlD
Almotriptan—CYP3A4—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0144	0.0296	CbGpPWpGaD
Almotriptan—MAOA—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0142	0.0293	CbGpPWpGaD
Almotriptan—HTR1D—brainstem—pharynx cancer	0.0141	0.0274	CbGeAlD
Almotriptan—MAOA—neck—pharynx cancer	0.0141	0.0273	CbGeAlD
Almotriptan—FMO3—Biological oxidations—ADH1B—pharynx cancer	0.0139	0.0286	CbGpPWpGaD
Almotriptan—FMO3—head—pharynx cancer	0.0137	0.0267	CbGeAlD
Almotriptan—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0126	0.026	CbGpPWpGaD
Almotriptan—MAOA—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0125	0.0257	CbGpPWpGaD
Almotriptan—MAOA—parotid gland—pharynx cancer	0.0115	0.0223	CbGeAlD
Almotriptan—MAOA—saliva-secreting gland—pharynx cancer	0.011	0.0213	CbGeAlD
Almotriptan—MAOA—brainstem—pharynx cancer	0.0107	0.0209	CbGeAlD
Almotriptan—FMO3—lymph node—pharynx cancer	0.00961	0.0187	CbGeAlD
Almotriptan—HTR1B—spinal cord—pharynx cancer	0.00906	0.0176	CbGeAlD
Almotriptan—CYP2E1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00874	0.018	CbGpPWpGaD
Almotriptan—MAOA—trachea—pharynx cancer	0.00846	0.0165	CbGeAlD
Almotriptan—MAOA—Biological oxidations—CNDP2—pharynx cancer	0.00837	0.0172	CbGpPWpGaD
Almotriptan—HTR1B—head—pharynx cancer	0.00805	0.0157	CbGeAlD
Almotriptan—HTR1D—head—pharynx cancer	0.0078	0.0152	CbGeAlD
Almotriptan—CYP2E1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00767	0.0158	CbGpPWpGaD
Almotriptan—MAOA—Biological oxidations—ADH7—pharynx cancer	0.00757	0.0156	CbGpPWpGaD
Almotriptan—CYP2C8—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00756	0.0156	CbGpPWpGaD
Almotriptan—CYP2C19—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00674	0.0139	CbGpPWpGaD
Almotriptan—MAOA—spinal cord—pharynx cancer	0.00668	0.013	CbGeAlD
Almotriptan—MAOA—Biological oxidations—ADH1B—pharynx cancer	0.00664	0.0137	CbGpPWpGaD
Almotriptan—CYP2C8—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00663	0.0136	CbGpPWpGaD
Almotriptan—CYP2D6—brainstem—pharynx cancer	0.00639	0.0124	CbGeAlD
Almotriptan—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0062	0.0128	CbGpPWpGaD
Almotriptan—MAOA—head—pharynx cancer	0.00594	0.0115	CbGeAlD
Almotriptan—CYP2C19—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00591	0.0122	CbGpPWpGaD
Almotriptan—CYP2E1—lymphoid tissue—pharynx cancer	0.00553	0.0108	CbGeAlD
Almotriptan—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00544	0.0112	CbGpPWpGaD
Almotriptan—CYP1A2—Phase II conjugation—CNDP2—pharynx cancer	0.00528	0.0109	CbGpPWpGaD
Almotriptan—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00526	0.0108	CbGpPWpGaD
Almotriptan—CYP2E1—Biological oxidations—CNDP2—pharynx cancer	0.00513	0.0106	CbGpPWpGaD
Almotriptan—CYP2E1—spinal cord—pharynx cancer	0.00501	0.00975	CbGeAlD
Almotriptan—CYP2E1—Biological oxidations—ADH7—pharynx cancer	0.00464	0.00956	CbGpPWpGaD
Almotriptan—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00461	0.00949	CbGpPWpGaD
Almotriptan—CYP2E1—head—pharynx cancer	0.00446	0.00867	CbGeAlD
Almotriptan—CYP2C8—Biological oxidations—CNDP2—pharynx cancer	0.00444	0.00914	CbGpPWpGaD
Almotriptan—MAOA—lymph node—pharynx cancer	0.00416	0.00809	CbGeAlD
Almotriptan—CYP2E1—Biological oxidations—ADH1B—pharynx cancer	0.00407	0.00838	CbGpPWpGaD
Almotriptan—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00406	0.00835	CbGpPWpGaD
Almotriptan—CYP2C8—Biological oxidations—ADH7—pharynx cancer	0.00401	0.00826	CbGpPWpGaD
Almotriptan—CYP2C19—Biological oxidations—CNDP2—pharynx cancer	0.00396	0.00815	CbGpPWpGaD
Almotriptan—CYP2D6—Biological oxidations—CNDP2—pharynx cancer	0.00364	0.0075	CbGpPWpGaD
Almotriptan—CYP2C19—Biological oxidations—ADH7—pharynx cancer	0.00358	0.00737	CbGpPWpGaD
Almotriptan—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00356	0.00732	CbGpPWpGaD
Almotriptan—CYP2D6—head—pharynx cancer	0.00353	0.00686	CbGeAlD
Almotriptan—CYP2C8—Biological oxidations—ADH1B—pharynx cancer	0.00352	0.00724	CbGpPWpGaD
Almotriptan—CYP2D6—Biological oxidations—ADH7—pharynx cancer	0.0033	0.00678	CbGpPWpGaD
Almotriptan—CYP2C19—Biological oxidations—ADH1B—pharynx cancer	0.00314	0.00647	CbGpPWpGaD
Almotriptan—CYP1A2—Biological oxidations—CNDP2—pharynx cancer	0.00309	0.00635	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—CNDP2—pharynx cancer	0.00299	0.00616	CbGpPWpGaD
Almotriptan—CYP2D6—Biological oxidations—ADH1B—pharynx cancer	0.00289	0.00595	CbGpPWpGaD
Almotriptan—CYP1A2—Biological oxidations—ADH7—pharynx cancer	0.00279	0.00575	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—ADH7—pharynx cancer	0.00271	0.00558	CbGpPWpGaD
Almotriptan—CYP1A2—Biological oxidations—ADH1B—pharynx cancer	0.00245	0.00504	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—CNDP2—pharynx cancer	0.00238	0.0049	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—ADH1B—pharynx cancer	0.00237	0.00489	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—B4GALT5—pharynx cancer	0.00227	0.00467	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—ADH7—pharynx cancer	0.00215	0.00443	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—ADH1B—pharynx cancer	0.00189	0.00389	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CNDP2—pharynx cancer	0.00143	0.00295	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—ADH7—pharynx cancer	0.00129	0.00266	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.0012	0.00247	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.0012	0.00247	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—ADH1B—pharynx cancer	0.00114	0.00234	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—B4GALT5—pharynx cancer	0.00108	0.00223	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CNDP2—pharynx cancer	0.000878	0.00181	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ADH7—pharynx cancer	0.000794	0.00163	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CNDP2—pharynx cancer	0.000759	0.00156	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ADH1B—pharynx cancer	0.000696	0.00143	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ADH7—pharynx cancer	0.000686	0.00141	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CNDP2—pharynx cancer	0.000677	0.00139	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—B4GALT5—pharynx cancer	0.000666	0.00137	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CNDP2—pharynx cancer	0.000623	0.00128	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ADH7—pharynx cancer	0.000613	0.00126	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ADH1B—pharynx cancer	0.000602	0.00124	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—B4GALT5—pharynx cancer	0.000575	0.00118	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ADH7—pharynx cancer	0.000564	0.00116	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ADH1B—pharynx cancer	0.000537	0.00111	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CNDP2—pharynx cancer	0.000528	0.00109	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—B4GALT5—pharynx cancer	0.000513	0.00106	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ADH1B—pharynx cancer	0.000494	0.00102	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ADH7—pharynx cancer	0.000477	0.000983	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—B4GALT5—pharynx cancer	0.000472	0.000972	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ADH1B—pharynx cancer	0.000419	0.000862	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CNDP2—pharynx cancer	0.000407	0.000839	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—B4GALT5—pharynx cancer	0.0004	0.000823	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ADH7—pharynx cancer	0.000368	0.000758	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ADH1B—pharynx cancer	0.000323	0.000665	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—EGFR—pharynx cancer	0.000312	0.000643	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—B4GALT5—pharynx cancer	0.000309	0.000636	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—EGFR—pharynx cancer	0.000306	0.00063	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCND1—pharynx cancer	0.000235	0.000484	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCND1—pharynx cancer	0.00023	0.000474	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—EGFR—pharynx cancer	0.000185	0.00038	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—EGFR—pharynx cancer	0.000181	0.000372	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TP53—pharynx cancer	0.000155	0.000319	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TP53—pharynx cancer	0.000152	0.000312	CbGpPWpGaD
